These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8478314)

  • 21. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
    Barry AL; Pfaller MA; Fuchs PC
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interactions of macrolides: emphasis on dirithromycin.
    Watkins VS; Polk RE; Stotka JL
    Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of dirithromycin against Chlamydia trachomatis.
    Segreti J; Kapell KS
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro.
    Mtairag EM; Abdelghaffar H; Labro MT
    J Antimicrob Chemother; 1994 Mar; 33(3):523-36. PubMed ID: 8040116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin.
    Jooné GK; Van Rensburg CE; Anderson R
    J Antimicrob Chemother; 1992 Oct; 30(4):509-23. PubMed ID: 1337069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of dirithromycin and erythromycin in bacterial pneumonia.
    Liippo K; Tala E; Puolijoki H; Brückner OJ; Rodrig J; Smits JP
    J Infect; 1994 Mar; 28(2):131-9. PubMed ID: 8034992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis.
    Mazzei T; Surrenti C; Novelli A; Biagini MR; Fallani S; Cassetta MI; Conti S; Surrenti E
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1556-9. PubMed ID: 10390202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of dirithromycin in pneumonia.
    Jacobson K
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():121-9. PubMed ID: 8478303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dirithromycin in the treatment of skin and skin structure infections.
    Derriennic M; Escande JP
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():159-68. PubMed ID: 8478307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interaction between dirithromycin or its metabolite, erythromycylamine, and oxidative polymorphonuclear metabolism.
    Moutard I; Gressier B; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC
    J Antibiot (Tokyo); 1997 Jan; 50(1):53-7. PubMed ID: 9066766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of dirithromycin on the normal oral and intestinal microflora.
    Eckernäs SA; Grahnén A; Nord CE
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):688-92. PubMed ID: 1748127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety profile of dirithromycin.
    Sides GD; Conforti PM
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():175-85. PubMed ID: 8478309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin.
    Labro MT; el Benna J; Abdelghaffar H
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():51-64. PubMed ID: 8478312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of erythromycylamine in human plasma by liquid chromatography-tandem mass spectrometry and its application in a bioequivalence study of dirithromycin enteric-coated tablets with a special focus on the fragmentation pattern and carryover effect.
    Cai HL; Wang F; Li HD; Peng WX; Zhu RH; Deng Y; Jiang P; Yan M; Hu SM; Lei SY; Chen C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():156-63. PubMed ID: 24424301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections.
    Wasilewski MM; Wilson MG; Sides GD; Stotka JL
    J Antimicrob Chemother; 2000 Aug; 46(2):255-62. PubMed ID: 10933649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of dirithromycin against Chlamydia pneumoniae.
    Roblin PM; Kutlin A; Sokolovskaya N; Hammerschlag MR
    J Antimicrob Chemother; 1997 May; 39(5):647-9. PubMed ID: 9184366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.